Stem cell transplantation

Organ responses after highdose melphalan and stemcell transplantation in AL amyloidosis

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: Impact of organ and hematologic response on overall survival after highdose melphalan and stemcell transplantation in patients with AL amyloidosis.
Fig. 2: Organ response according to hematologic response at 6 months in patients with AL amyloidosis treated with HDM/SCT as frontline therapy.


  1. 1.

    Merlini G, Dispenzieri A, Sanchorawala V, Schonland SO, Palladini G, Hawkins PN, et al. Systemic immunoglobulin light chain amyloidosis. Nat Rev Dis Prim. 2018;4:38.

    Article  Google Scholar 

  2. 2.

    Vaxman I, Dispenzieri A, Muchtar E, Gertz M. New developments in diagnosis, risk assessment and management in systemic amyloidosis. Blood Rev. 2020;40:100636.

    CAS  Article  Google Scholar 

  3. 3.

    Sharpley FA, Petrie A, Mahmood S, Sachchithanantham S, Lachmann HJ, Gillmore JD, et al. A 24-year experience of autologous stem cell transplantation for light chain amyloidosis patients in the United Kingdom. Br J Haematol. 2019;187:642–52.

    CAS  Article  Google Scholar 

  4. 4.

    Sidana S, Sidiqi MH, Dispenzieri A, Buadi FK, Lacy MQ, Muchtar E, et al. Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosis. Am J Hematol. 2019;94:1020–6.

    CAS  Article  Google Scholar 

  5. 5.

    Sanchorawala V, Sun F, Quillen K, Sloan JM, Berk JL, Seldin DC. Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem cell transplantation: 20-year experience. Blood. 2015;126:2345–7.

    Article  Google Scholar 

  6. 6.

    Browning S, Quillen K, Sloan JM, Doros G, Sarosiek S, Sanchorawala V. Hematologic relapse in AL amyloidosis after high-dose melphalan and stem cell transplantation. Blood. 2017;130:1383–6.

    CAS  Article  Google Scholar 

  7. 7.

    Dember LM, Sanchorawala V, Seldin DC, Wright DG, LaValley M, Berk JL, et al. Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on al amyloidosis-associated renal disease. Ann Intern Med. 2001;134:746–53.

    CAS  Article  Google Scholar 

  8. 8.

    Salinaro F, Meier-Ewert HK, Miller EJ, Pandey S, Sanchorawala V, Berk JL, et al. Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosis. Eur Heart J Cardiovasc Imaging. 2017;18:1057–64.

    Article  Google Scholar 

  9. 9.

    Girnius S, Seldin DC, Skinner M, Finn KT, Quillen K, Doros G, et al. Hepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis associated liver disease. Haematologica. 2009;94:1029–32.

    CAS  Article  Google Scholar 

  10. 10.

    Cibeira MT, Sanchorawala V, Seldin DC, Quillen K, Berk JL, Dember LM, et al. Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients. Blood. 2011;118:4346–52.

    CAS  Article  Google Scholar 

  11. 11.

    Leung N, Dispenzieri A, Fervenza FC, Lacy MQ, Villicana R, Cavalcante JL, et al. Renal response after high-dose melphalan and stem cell transplantation is a favorable marker in patients with primary systemic amyloidosis. Am J Kidney Dis. 2005;46:270–7.

    CAS  Article  Google Scholar 

  12. 12.

    Palladini G, Dispenzieri A, Gertz MA, Kumar S, Wechalekar A, Hawkins PN, et al. New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes. J Clin Oncol. 2012;30:4541–9.

    CAS  Article  Google Scholar 

  13. 13.

    Palladini G, Hegenbart U, Milani P, Kimmich C, Foli A, Ho AD, et al. A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis. Blood. 2014;124:2325–32.

    CAS  Article  Google Scholar 

  14. 14.

    Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol. 2005;79:319–28.

  15. 15.

    Lilleness B, Ruberg FL, Mussinelli R, Doros G, Sanchorawala V. Development and validation of a survival staging system incorporating BNP in patients with light chain amyloidosis. Blood. 2019;133:215–23.

    CAS  Article  Google Scholar 

  16. 16.

    Lilleness B, Doros G, Ruberg FL, Sanchorawala V. Establishment of brain natriuretic peptide - based criteria for evaluating cardiac response to treatment in light chain (AL) amyloidosis. Br J Haematol. 2020;188:424–7.

    CAS  Article  Google Scholar 

Download references


The authors acknowledge their colleagues in the Amyloidosis Center, Cancer Clinical Trials Office, and Center for Cancer and Blood Disorders at Boston Medical Center, who assisted with the multidisciplinary evaluation and treatment of the patients with AL amyloidosis.

Author information




RS and VS designed research, performed research, analyzed data, and wrote the paper. RS performed statistical analysis. SS performed research, analyzed data, and critically reviewed the paper. JMS and DB critically reviewed the paper.

Corresponding author

Correspondence to Vaishali Sanchorawala.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Szalat, R., Sarosiek, S., Havasi, A. et al. Organ responses after highdose melphalan and stemcell transplantation in AL amyloidosis. Leukemia (2020).

Download citation